237 related articles for article (PubMed ID: 14506273)
1. Functional domains in the carnitine transporter OCTN2, defective in primary carnitine deficiency.
Amat di San Filippo C; Wang Y; Longo N
J Biol Chem; 2003 Nov; 278(48):47776-84. PubMed ID: 14506273
[TBL] [Abstract][Full Text] [Related]
2. Tyrosine residues affecting sodium stimulation of carnitine transport in the OCTN2 carnitine/organic cation transporter.
Amat di San Filippo C; Longo N
J Biol Chem; 2004 Feb; 279(8):7247-53. PubMed ID: 14665638
[TBL] [Abstract][Full Text] [Related]
3. Glycosylation of the OCTN2 carnitine transporter: study of natural mutations identified in patients with primary carnitine deficiency.
Filippo CA; Ardon O; Longo N
Biochim Biophys Acta; 2011 Mar; 1812(3):312-20. PubMed ID: 21126579
[TBL] [Abstract][Full Text] [Related]
4. A missense mutation in the OCTN2 gene associated with residual carnitine transport activity.
Wang Y; Kelly MA; Cowan TM; Longo N
Hum Mutat; 2000; 15(3):238-45. PubMed ID: 10679939
[TBL] [Abstract][Full Text] [Related]
5. Wide tolerance to amino acids substitutions in the OCTN1 ergothioneine transporter.
Frigeni M; Iacobazzi F; Yin X; Longo N
Biochim Biophys Acta; 2016 Jun; 1860(6):1334-42. PubMed ID: 26994919
[TBL] [Abstract][Full Text] [Related]
6. Molecular and functional identification of sodium ion-dependent, high affinity human carnitine transporter OCTN2.
Tamai I; Ohashi R; Nezu J; Yabuuchi H; Oku A; Shimane M; Sai Y; Tsuji A
J Biol Chem; 1998 Aug; 273(32):20378-82. PubMed ID: 9685390
[TBL] [Abstract][Full Text] [Related]
7. Abnormal sodium stimulation of carnitine transport in primary carnitine deficiency.
Wang Y; Meadows TA; Longo N
J Biol Chem; 2000 Jul; 275(27):20782-6. PubMed ID: 10783384
[TBL] [Abstract][Full Text] [Related]
8. Mutations in the organic cation/carnitine transporter OCTN2 in primary carnitine deficiency.
Wang Y; Ye J; Ganapathy V; Longo N
Proc Natl Acad Sci U S A; 1999 Mar; 96(5):2356-60. PubMed ID: 10051646
[TBL] [Abstract][Full Text] [Related]
9. Mutations in novel organic cation transporter (OCTN2), an organic cation/carnitine transporter, with differential effects on the organic cation transport function and the carnitine transport function.
Seth P; Wu X; Huang W; Leibach FH; Ganapathy V
J Biol Chem; 1999 Nov; 274(47):33388-92. PubMed ID: 10559218
[TBL] [Abstract][Full Text] [Related]
10. Molecular and functional characterization of organic cation/carnitine transporter family in mice.
Tamai I; Ohashi R; Nezu JI; Sai Y; Kobayashi D; Oku A; Shimane M; Tsuji A
J Biol Chem; 2000 Dec; 275(51):40064-72. PubMed ID: 11010964
[TBL] [Abstract][Full Text] [Related]
11. Functional analysis of mutations in the OCTN2 transporter causing primary carnitine deficiency: lack of genotype-phenotype correlation.
Wang Y; Taroni F; Garavaglia B; Longo N
Hum Mutat; 2000 Nov; 16(5):401-7. PubMed ID: 11058897
[TBL] [Abstract][Full Text] [Related]
12. Genotype-phenotype correlation in primary carnitine deficiency.
Rose EC; di San Filippo CA; Ndukwe Erlingsson UC; Ardon O; Pasquali M; Longo N
Hum Mutat; 2012 Jan; 33(1):118-23. PubMed ID: 21922592
[TBL] [Abstract][Full Text] [Related]
13. Studies on functional sites of organic cation/carnitine transporter OCTN2 (SLC22A5) using a Ser467Cys mutant protein.
Ohashi R; Tamai I; Inano A; Katsura M; Sai Y; Nezu J; Tsuji A
J Pharmacol Exp Ther; 2002 Sep; 302(3):1286-94. PubMed ID: 12183691
[TBL] [Abstract][Full Text] [Related]
14. Functional regions of organic cation/carnitine transporter OCTN2 (SLC22A5): roles in carnitine recognition.
Inano A; Sai Y; Kato Y; Tamai I; Ishiguro M; Tsuji A
Drug Metab Pharmacokinet; 2004 Jun; 19(3):180-9. PubMed ID: 15499185
[TBL] [Abstract][Full Text] [Related]
15. Molecular cloning and functional characterization of the OCTN2 transporter at the RBE4 cells, an in vitro model of the blood-brain barrier.
Friedrich A; Prasad PD; Freyer D; Ganapathy V; Brust P
Brain Res; 2003 Apr; 968(1):69-79. PubMed ID: 12644265
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological and pathophysiological roles of carnitine/organic cation transporters (OCTNs: SLC22A4, SLC22A5 and Slc22a21).
Tamai I
Biopharm Drug Dispos; 2013 Jan; 34(1):29-44. PubMed ID: 22952014
[TBL] [Abstract][Full Text] [Related]
17. Carnitine transport by organic cation transporters and systemic carnitine deficiency.
Lahjouji K; Mitchell GA; Qureshi IA
Mol Genet Metab; 2001 Aug; 73(4):287-97. PubMed ID: 11509010
[TBL] [Abstract][Full Text] [Related]
18. Epitope shared by functional variant of organic cation/carnitine transporter, OCTN1, Campylobacter jejuni and Mycobacterium paratuberculosis may underlie susceptibility to Crohn's disease at 5q31.
Lamhonwah AM; Ackerley C; Onizuka R; Tilups A; Lamhonwah D; Chung C; Tao KS; Tellier R; Tein I
Biochem Biophys Res Commun; 2005 Dec; 337(4):1165-75. PubMed ID: 16246312
[TBL] [Abstract][Full Text] [Related]
19. Functional genetic variation in the basal promoter of the organic cation/carnitine transporters OCTN1 (SLC22A4) and OCTN2 (SLC22A5).
Tahara H; Yee SW; Urban TJ; Hesselson S; Castro RA; Kawamoto M; Stryke D; Johns SJ; Ferrin TE; Kwok PY; Giacomini KM
J Pharmacol Exp Ther; 2009 Apr; 329(1):262-71. PubMed ID: 19141711
[TBL] [Abstract][Full Text] [Related]
20. Carnitine transport: pathophysiology and metabolism of known molecular defects.
Tein I
J Inherit Metab Dis; 2003; 26(2-3):147-69. PubMed ID: 12889657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]